Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Eletriptan hydrobromide
Drug ID BADD_D00756
Description Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches.
Indications and Usage For the acute treatment of migraine with or without aura in adults.
Marketing Status Prescription
ATC Code N02CC06
DrugBank ID DB00216
KEGG ID D01973
MeSH ID C115647
PubChem ID 656631
TTD Drug ID D02DMQ
NDC Product Code 71335-1830; 48087-0090; 27241-040; 0378-4288; 68382-923; 48087-0102; 65162-042; 59651-105; 65977-0059; 59651-104; 10829-0558; 0049-2340; 0049-2330; 65015-719; 65162-043; 70771-1107; 59762-2321; 0378-4287; 70771-1108; 68382-922; 10829-0557; 0093-8310; 63629-8320; 63126-904; 27241-039; 59651-101; 0093-8311; 59762-2322
Synonyms eletriptan | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole | UK 166,044 | UK-166044 | UK 166044 | UK-166,044 | Relpax | UK-116044-04 | UK-116,044-04 | eletriptan hydrobromide | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide | 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide
Chemical Information
Molecular Formula C22H27BrN2O2S
CAS Registry Number 177834-92-3
SMILES CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Breast pain21.05.05.003--
Breath odour07.01.06.002--Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Catatonia19.11.01.001--Not Available
Cerebrovascular disorder24.03.05.002; 17.08.02.002--Not Available
Chest discomfort22.02.08.001; 08.01.08.019; 02.02.02.009--Not Available
Chest pain08.01.08.002; 02.02.02.011; 22.02.08.003--Not Available
Chills15.05.03.016; 08.01.09.001--
Choking sensation22.02.05.002; 19.01.02.002--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Conjunctivitis06.04.01.002; 11.01.06.012--
Constipation07.02.02.001--
Conversion disorder19.24.01.001--Not Available
Coordination abnormal17.02.02.004--Not Available
Cough22.02.03.001--
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.002--
Dementia17.03.01.001; 19.20.02.001--Not Available
Depression19.15.01.001--
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Diplopia17.17.01.005; 06.02.06.002--Not Available
Dizziness02.01.02.004; 24.06.02.007; 17.02.05.003--
Dry eye06.08.02.001--
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Dysphonia22.02.05.005; 19.19.03.002; 17.02.08.004--
Dyspnoea22.02.01.004; 02.01.03.002--
Ear disorder04.03.01.001--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 7 Pages